CrushSCI.com
85.9平均天数
64中位天数
34最短天数
176最长天数
3742025发文量

Paper Review Records

全部论文审稿周期

14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

39 天

Vaccination against neoantigens induced in cross-priming cDC1 in vivo

作者
Emily S. Clark; Ana Paula Benaduce; Wasif N. Khan; Olivier Martinez; Eli Gilboa展开收起
作者单位
1. Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, USA; 2. Department of Biological Sciences, Florida International University, Miami, USA; 3. Mnemo Therapeutics, Paris, France; 4. Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, USA展开收起
PDF源文件 DOI 网页
45 天

Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases

作者
Celine Man Ying Li; Yoko Tomita; Bimala Dhakal; Teresa Tin; Runhao Li; Josephine A. Wright; Laura Vrbanac; Susan L. Woods; Paul Drew; Timothy Price; Eric Smith; Guy J. Maddern; Kevin Fenix展开收起
作者单位
1. Discipline of Surgery, Adelaide Medical School, The University of Adelaide, Adelaide, Australia; 2. The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia; 3. Medical Oncology, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, Australia; 4. Precision Medicine, South Australian Health and Medical Research Institute, Adelaide, Australia; 5. Department of Medical Specialties, Adelaide Medical School, The University of Adelaide, Adelaide, Australia展开收起
PDF源文件 DOI 网页
46 天

Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53

作者
Brendan L. C. Kinney; Sreenivasulu Gunti; Vikash Kansal; Connor J. Parrish; Nabil F. Saba; Yong Teng; Mary Katherine Henry; Fang-Yi Su; Gabriel A. Kwong; Nicole C. Schmitt展开收起
作者单位
1. Department of Otolaryngology – Head and Neck Surgery, Head and Neck Cancer Program, Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA; 2. Winship Cancer Institute, Emory University, Atlanta, USA; 3. National Institute of Deafness and Communication Disorders, NIH, Bethesda, USA; 4. Saint Louis University School of Medicine, St. Louis, USA; 5. Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, USA; 6. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory School of Medicine, Atlanta, USA; 7. Emory University School of Medicine, Atlanta, USA展开收起
PDF源文件 DOI 网页
108 天

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

作者
Xinfeng Chen; Binghe Tan; Haizhou Xing; Xuan Zhao; Yu Ping; Zhen Zhang; Jianmin Huang; Xiujuan Shi; Na Zhang; Boxu Lin; Weijie Cao; Xin Li; Xudong Zhang; Ling Li; Zhongxing Jiang; Mingzhi Zhang; Wei Li; Mingyao Liu; Bing Du; Yi Zhang展开收起
作者单位
1. Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; 4. BRL Medicine Inc, Shanghai, China; 5. Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 6. State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou, China; 7. School of Life Sciences, Zhengzhou University, Zhengzhou, China; 8. Engineering Key Laboratory for Cell Therapy of Henan Province, Zhengzhou, China展开收起
PDF源文件 DOI 网页
132 天

Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells

作者
Libao Liu; Laurie Rangan; Nathan Vanalken; Qianqian Kong; Susan Schlenner; Steven De Jonghe; Dominique Schols; Tom Van Loy展开收起
作者单位
1. Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium; 2. Laboratory of Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium展开收起
PDF源文件 DOI 网页
82 天

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

作者
M Costa-Garcia; JJ Rojas; MD Ramos; P Barlabé; P Calvo; J Navas; R Alemany; R Moreno展开收起
作者单位
1. Cancer Immunotherapy Group, Oncobell and iProCURE programs, IDIBELL-Institut Català d’Oncologia, l’Hospitalet de Llobregat, Barcelona, Spain; 2. Immunology Unit, Department of Pathology and Experimental Therapies, School of Medicine, University of Barcelona-UB, Barcelona, Spain; 3. Immunity, Inflammation, and Cancer Group, Oncobell program, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, l’Hospitalet de Llobregat, Barcelona, Spain; 4. Program of Regenerative Medicine, Centre for Applied Medical Research (CIMA), University of Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Pamplona, Spain展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。